Skip Navigation

Medical Expert - Waldemar Debinski, MD, PhD

Area of Expertise: Cancer - Brain
Media Contact: Marguerite Beck
Media Office: 336-716-2415 Media Mobile: 336-480-8599
Patient Contact: Health On-Call® 1-800-446-2255

Waldemar Debinski, MD, PhD

Professor of Surgery - Neurosurgery

Debinski, director of the Brain Tumor Center of Excellence at Wake Forest Baptist, is a physician-scientist who pioneered a method to destroy malignant brain tumor cells without harming healthy cells. A drug developed by Debinski was an "unanticipated success" in early clinical trials and is now going through final testing in a phase-3 study. He also researches brain tumor vaccines and new imaging techniques. He holds eight patents and has published more than 200 scientific reports. He won the Society of Neuro-Oncology's annual award for Excellence in Basic Research.


Targeted therapies for brain cancer, brain cancer vaccine research, imaging, malignant brain tumors, Brain Tumor Center of Excellence, brain tumor vaccine


Brain Cancer Research Project Receives 1 5 Million Federal Grant

A Wake Forest Baptist Medical Center-based research program aimed at developing new ways to treat one of the most common and most malignant types of primary brain tumors has been awarded a $1.5 million grant by the National Cancer Institute (NCI) of the National Institutes of Health.

Cancer Researchers at Wake Forest Baptist Receive $9 Million Grant to Study Aggressive Brain Cancer

Glioblastoma is the most aggressive cancer that originates in the brain. Current therapies can slow the disease, but more often than not can’t cure it. 

Invading Cancer Cells

Researchers have created a "designer protein" that can not only target a cancer cell, but can also invade that cell and attack its DNA. Lead researcher Waldemar Debinski, MD, PhD, says his findings open a new door in cancer research.

New Brain Tumor Vaccine to Be Tested in Humans
For patients with low-grade gliomas, or slow growing brain tumors, a shot in the arm might soon lead to a new treatment therapy.
Novel Brain Tumor Vaccine Acts Like Bloodhound to Locate Cancer Cells

A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.

Related Experts

Glenn J. Lesser, MD
Professor of Internal Medicine - Hematology and Oncology
Director, Medical Neuro-Oncology
Area of Expertise: Cancer - Brain
Area of Expertise: Cancer - Pain Management
Area of Expertise: Cancer - Symptom Management

Lesser, a medical oncologist, directs clinical trials through Wake Forest Baptist's inclusion in a consortium of centers that test novel treatments for brain tumors. He was involved in inventing a device implanted under the skin to release a continuous dose of pain medication. Lesser

Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.